A Singapore Pilot Study to Assess Neurovision in Treatment of Low Myopia
A Singapore Pilot Study To Evaluate The Efficacy Of A Computerized System For The Vision Improvement Of People With Low Myopia
1 other identifier
interventional
N/A
1 country
1
Brief Summary
To assess how well and safe is Neurovision technology in improving the vision of people with low myopia in Singapore
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2003
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2004
CompletedFirst Submitted
Initial submission to the registry
July 3, 2006
CompletedFirst Posted
Study publicly available on registry
July 4, 2006
CompletedJune 24, 2010
January 1, 2010
1.6 years
July 3, 2006
June 23, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Manifest Subjective and Objective refraction
Cycloplegic Objective refraction
Accommodation amplitude
Distance visual acuity (Uncorrected Visual Acuity - UCVA, and BCVA)
Near visual acuity
Contrast sensitivity (corrected and uncorrected)
Visual Evoked Potential (VEP) and Multifocal VEP
Interventions
Eligibility Criteria
You may qualify if:
- The subject's cycloplegic spherical equivalence in the worst eye does not exceed -1.5 DS and the astigmatism does not exceed 0.50 DC.
- The subject's refractive status is stable, with no increase beyond 0.5D in sphere or cylinder over the last six months.
- The subject's age is between 17-55 years.
- The subject's uncorrected visual acuity 0.7 LogMar
- The subject's best corrected visual acuity 0.05 LogMar
- The subject is cognitively intact and is able to follow multiple step instructions.
- The subject is able and willing to attend all study sessions and visits at the required frequency:
- The total number of treatments is individual, approximately 30.
- The required pace for the treatment sessions is at least 3 sessions per week.
- No foreseen interruptions longer than 2 weeks during the treatment course.
- Subject (or subject's parent/legal guardian if subject is less than 21 years of age at study entry) agrees to sign the Informed Consent Form (See Appendix D)
You may not qualify if:
- The subject suffers from any other eye disease(s) or other causes for the reduced visual acuity, aside from myopia and/or astigmatism.
- The subject suffers from myopia-related visual complications resulting in visual loss, including myopic macular degeneration, myopic cataract and previous or pre-existing myopic retinal detachment.
- The subject is suffering from Diabetes Mellitus.
- The subject has previously undergone a refractive surgery procedure in either eye.
- The subject is or may be pregnant.
- The subject has an activity limitation due to medical disorders (including migraines, seizure disorders, etc.), medications, or emotional status that might potentially impair the subject's ability to perform the treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Singapore National Eye Centrelead
- Singapore Eye Research Institutecollaborator
- NeuroVisioncollaborator
Study Sites (1)
Singapore Eye Research Institute
Singapore, 168751, Singapore
Related Publications (8)
Polat U, Ma-Naim T, Belkin M, Sagi D. Improving vision in adult amblyopia by perceptual learning. Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6692-7. doi: 10.1073/pnas.0401200101. Epub 2004 Apr 19.
PMID: 15096608BACKGROUNDPolat U, Mizobe K, Pettet MW, Kasamatsu T, Norcia AM. Collinear stimuli regulate visual responses depending on cell's contrast threshold. Nature. 1998 Feb 5;391(6667):580-4. doi: 10.1038/35372.
PMID: 9468134BACKGROUNDLevi DM, Polat U, Hu YS. Improvement in Vernier acuity in adults with amblyopia. Practice makes better. Invest Ophthalmol Vis Sci. 1997 Jul;38(8):1493-510.
PMID: 9224277BACKGROUNDPolat U, Norcia AM. Neurophysiological evidence for contrast dependent long-range facilitation and suppression in the human visual cortex. Vision Res. 1996 Jul;36(14):2099-109. doi: 10.1016/0042-6989(95)00281-2.
PMID: 8776476BACKGROUNDSagi D, Tanne D. Perceptual learning: learning to see. Curr Opin Neurobiol. 1994 Apr;4(2):195-9. doi: 10.1016/0959-4388(94)90072-8.
PMID: 8038576BACKGROUNDPolat U, Sagi D. Spatial interactions in human vision: from near to far via experience-dependent cascades of connections. Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1206-9. doi: 10.1073/pnas.91.4.1206.
PMID: 8108388BACKGROUNDPolat U, Sagi D. Lateral interactions between spatial channels: suppression and facilitation revealed by lateral masking experiments. Vision Res. 1993 May;33(7):993-9. doi: 10.1016/0042-6989(93)90081-7.
PMID: 8506641BACKGROUNDLevi DM, Polat U. Neural plasticity in adults with amblyopia. Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6830-4. doi: 10.1073/pnas.93.13.6830.
PMID: 8692904BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Donald Tan, FRCS
Singapore Eye Research Institute
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
July 3, 2006
First Posted
July 4, 2006
Study Start
March 1, 2003
Primary Completion
October 1, 2004
Study Completion
October 1, 2004
Last Updated
June 24, 2010
Record last verified: 2010-01